Final-New Material-Rachael Flashcards

(95 cards)

1
Q

Androgens

A
  • androstenedione, DHEA, testrosterone, DHT
    • Listed in order of potency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Estrogens and Progestogens

A
  • estrone, estriole, beta-estradiol (“estrogen”)
  • Progesterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hormone Signaling

A
  • Non-polar hormones: secretion stimulated by stimulating enzymatic reactions
    • Hormone bound to proteins in circulation
    • Modification by enzymes in target cells
      • Testosterone→dihydrotestosterone (DHT), more potent
        • Enzyme: 5-alpha-reductase
      • Androgens→estrogens
        • Enzyme: aromatase
    • Enzymes can be drug targets
    • Free hormones diffuses across plasma membrane of target cell
    • Signaling via intracellular receptors that act as transcription factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hormone Feedback Cycle

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gametes Form by Meiosis

A
  • Germ-cell: gametes and the gamete precursors
  • 23 pairs of homologous chromosomes; 22 autosomes; 2 sex chromosomes
  • Haploid cell has 23 single chromosomes
  • In 1st division, the homologous chromosome pair up.
    • Then they divide
    • Crossing-over; recombination; variability
    • Independent assortment; some of maternal and paternal end up dividing together
  • In 2nd division, the chromatids divide up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nondisjunction lead to aneuploidy

A
  • At first division: 2 of four have n-1, 2 of four have n+1
  • At second division: 2 of four are normal, 1 n+1, 1 n-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Karyotype via amniocentesis or chorionic villus sampling and Cell Free DNA sampling

A
  • Fetal cells: invasive: miscarriage or infection
  • Placenta has fetal and maternal cells
    • Branching is chorionic plate
    • Protrudes into space created in endometrial spaceàmaternal blood flow
  • Cell-free fetal DNA analysis:
    • Small fragments of DNA enter the maternal circulation
    • Early, non-invasive, blood draw
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hormone regulation: pulsatile secretion of GnRH

A
  • GnRH in the hypothalamus
  • Anterior pituitary: gonadotropins
    • Follicle stimulating hormone (FSH)
    • Luteinizing hormone (LH)
    • Negative feedback regulation by gonadal steroids
    • *Some positive feedback occurs in female
  • Gonadotropin (FSH, LH) secretion is stimulated by pulsatile GnRH, inhibited by continuous GnRH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Review of Pituitary Hormones

A
  • 3 hormone chain of command
  • Magnocellular vs. parvocellular cell
  • Magnocellular release to posterior pituitary
  • Parvocellular release to median eminence, delivered directly to anterior pituitary (adenhypophesis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Continuous Treatment with GnRH

A
  • Continuous treatment with GnRH agonist (eg. Leuprolide) used to turn off reproductive function
  • Precocious puberty
  • Androgen deprivation therapy for prostate cancer
    • Decreased secretion of testosterone
  • Used in treatment of prostate cancer, endometriosis, precocious puberty
  • Cycle control for IVF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chronology of reproductive function

A
  • GnRH secretion is high during sexual differentiation, low during childhood, and high after puberty
  • Sexual differentiation is before birth
  • Gonadal steroid secretion during lifetime in females and males
    • Females spike up and down; drops in menopause (estrogen, progesterone)
      • Early menopause: look for increase FSH, would occur because of removal of negative feedback inhibition
    • Males spike and then slowly decrease with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leptin and GnRH

A
  • Leptin is part of a negative feedback loop to control adiposity
  • Need leptin to allow GnRH level to increase
  • The obese mutant mouse fails to make leptin and suffers from hypogonadotropic hypogonadism
  • Leptin is permissive for GnRH secretion
    • In abscence, no GnRH, low FSH and LH, decreased gonadal function, infertility
    • Doesn’t cause start of period: other factors turning on
    • At certain level of leptin, factors more likely to turn on
      • Leptin, environmental estrogens
  • Hypoleptinemia in women
    • Low body fat, low leptin secretion, amenorrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Male Reproductive Anatomy

A
  • Sperm develop in seminiferous tubules→epididymis→ductus deferens (vas deferens)→ejaculatory duct→urethra
  • Semen: spermatozoa plus seminal fluid
  • Seminal fluid made by accessory glands:
    • Bulbourethral glands: make least amount of stuff neutralizes traces of urine
    • Prostate gland (1)
    • Seminal vesicle (2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benign Prostatic Hypertrophy (BPH)

A
  • Causes urinary symptoms
  • Symptoms in 1/3 men over 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BPH Drugs

A
  • Alpha adrenergic antagonists: Tamsulosin (Flomax)
    • Relax smooth muscle in urethra
    • Really specific for alpha receptors in the urethra and less likely to bind other subtypes-Not have to worry about blood pressure effects as much
  • 5-alpha reductase inhibitors
    • Dutasteride, finasteride
    • Prostate heavily influenced by DHT
    • Prevent testosterone to DHT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prostate Cancer

A
  • Tends to be very slow growing
  • Incidence and mortality of prostate cancer: effect of increased screening with PSA test
    • Not specific to cancer because BPH also tests positive
    • Lots of cancer diagnosis, over diagnosis
      • Mortality didn’t actually go down
    • Early screening has no benefit on cancer mortality rate
  • Best option in most cases is to leave it alone
    • Treatment increases morbidity and side effects
    • Urinary, defecation, etc. can be messed up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Spermatogenesis

A
  • Differentiation from spermatid to spermatozoon
  • Head of sperm:
    • Nucleus
    • Vesicle called the acrosome
      • Contains digestive enzymes
      • Important in fertilization
  • Sperm made: 100 Million per day, 1000 per second
    • Need 15 million sperm per mL for fertility
  • Leydig cells: make testosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Migration of Developing Sperm in Seminiferous Tubule (Figure)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sertoli Cells

A
  • Like epithelium that wrap around and hang onto developing germ cells
  • Create blood testis barrier
    • Between inside of seminiferous tubule and blood
    • Tight junx between sertoli cells
    • Basal: spermatagonia
    • Central: meiosis and mature gametes
    • Isolates from immune system (central compartment)
  • Nourishing/paracrine signaling required for spermtagonenisis
  • Receptors for FSH and testosterone
  • Produce androgen binding protein
  • Endocrine cells that produce:
    • Inhibin: negative feedback
    • Mulllerian inhibiting substance (MIS): involved in sexual differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sertoli Cell Functions: Summary

A
  • Blood testis barrier
  • Support gamete development
  • Responds to FSH, testosterone
  • Synthesize androgen binding protein
  • Secrete hormones:
    • Inhibin
    • Mullerian Inhibiting Substance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Male Hormonal Regulation

A
  • Leydig cells bind to LH
  • Sertoli cells bind to FSH
  • Negative feedback of tropin
  • Not on and off: rather fine tuning
  • Muscle mass, bone growth, protein synthesis, secondary sexual structure, sex drive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Physiology of erection

A
  • 1 corpus sponginosum and 2 corpus cavernosa
  • Erectile tissues that are vascular spaces that can fill up with blood and become engorged
    • Relaxation of arterials and smooth muscles allows blood to flow in
    • Maintenance helped because filling up compresses the veins
  • neural inputs to arterial smooth muscle of the penis:
    • NANC (nonadrenergic, noncholinergic) neurons:
    • Releases nitric oxide as neurotransmitter
    • Nitrergic neurons
  • Sympathetic neurons:
    • Release norepinephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Erectile Dysfunction Drugs

A
  • Phosphodiesterase inhibitors
  • Oral drugs to treat ED
  • NO stimulates guanylate cyclase
    • Make cGMP
    • Lead to decrease in Ca and relaxation
  • PDE inactivates pathway by cleaving cGMP
  • Sildenafil, vardenafil, tadalafil, avanafil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Ejaculation

A
  • Semen from urethra
  • Smooth muscle contraction around the ducts
  • Depends on the sympathetic input to smooth muscle
  • Vas deferens + Ejaculatory Duct
  • Glands
  • Internal urethral sphincter
  • Release of semen from penis
    • Contraction of smooth muscle in urethra
    • Contraction of skeletal muscles in pelvic floor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Sexually Indifferent Stage
* During embryonic development * Adjacent to each primitive gonad * Wolffian (mesonephric) ducts are more medial * Müllerian (paramesonephric) ducts are more lateral, but then fuse in the midline more caudally
26
Sexual Determination: Male
* Sexual determination: depends upon the sex chromosomes, X and Y * SRY gene on Y chromosome * activates a gene network that directs the gonads to develop as testes * No SRY, goes to ovaries * Testes generate regulatory molecules * MIS=Mullerian Inhibiting Substance * peptide hormone
27
Sexual Determination: Female
* Female in absence of SRY gene
28
MIS Information
* produced in the ovary (after it differentiates) by granulosa cells * expressed mainly by small growing follicles * level of MIS is thus a good indicator of the size of the ovarian reserve * Used in IVF to predict how the woman will respond to controlled ovarian stimulation
29
Androgen Insensitivity Syndrome
* Mutation in androgen receptor * "complete androgen insensitivity" * Testes develop * Externally as a female * development of the male external genitalia depends upon androgen * Breasts develop because testosterone converted to estrogen * Recognized via amenorrhea * Uterus never developed because MIS caused regression * No armpit or pubic hair because these depend on androgen signaling
30
Treatment for Androgen Insensitivity Syndrome
* Removal of abdominal testes * gonadectomy * Increased risk for testicular cancer * Cryptorchidism (failure of testes to descend) * Low androgen levels * Wait until early adulthood and then gonadectomy so that naturally goes through puberty * After gonadectomy, kept on hormone therapy
31
Mutation in 5-alpha-reductase
* Penis and prostate development depends upon dihydrotestosterone (DHT) * Mutation in 5-alpha-reductase type 2 * Born externally female * Hypospadias * Urethra not in phallus but in the perineum * At pubery the large levles of testosterone stimulate the development of male structures * Male secondary structures develop * Initially raised as girls and then develop male gender identity *
32
Other Ovarin Development Signals
* Occurs in absence of SRY gene * But doesn't occur by default * Several genes (RSPO1, WNT4, FOXL2) have been shown to be necessary to initiate ovarian development * actively repress gene network for testes development
33
Comparing Male vs. Female: * Spermatagonia * Spermatocyte divisions * # of germ cells
34
Female Oogensis Flowchart
35
Oocytes develop into follicles
* Prior to birth, oogonia stop proliferating * At birth, germ cells in ovaries are primary oocytes * Initiated meiosis but are then in meiotic arrest * Oocyte+support cells=follicle * Not developing=primordial follicles * oocyte in meiotic arrest surrounded by a single layer of follicle cells * Once starts to develop: * Oocyte enlarges * Follicle cells differentiate to granulosa cells, proliferate * Zona pellucida: glycoproteins * Spindle shaped theca cells * Fluid-filled antrum
36
Follicle Development: Independent Development
* Local signals in ovary cause follicles to develop into early antral stage * Independent of gonadotropins * Before puberty and any time in monthly cycle
37
Follicle Development: Growth Phase
* Follicles that have undergone initial development * Further stimulated by rising gonadotropins (FSH) and (LH) * If intial development not later hormonally supported, undergoes **atresia** * 99.9% * Happens all throughout childhood * Fewer ovulations, less ovarian cancer risk * Growing, antral follicles
38
Follicle Development: Dominant Follicle
* Dominant follicle selected by day 7 * Day 7-14 matures * Egg and small cluster of granulosa cells detaches from wall and follicle floats free within antrum * Ovulation on day 14 * **Follicular phase**
39
Follicle Development: Post Ovulation
* Remaining follicle cells into corpus luteum * Granulosa cells increase, BM broken down, invaded by blood vessels * Corpus luteum secretes progesterone and estrogen * Degenerates day 25 and 28 when LH levels decline * Fertilized embryo will make chorionic gonadotropin, LH analog that allows corpus luteum to persist during first trimester * **Luteal Phase**
40
Hormonal Regulation: Early Follicular Phase
* Growth stimulated by Gn * Decreasing estrogen and progesterone from end of cycle release the negative feedback on the anterior pituitary * FSH=granulosa cells * LH=theca cells * Start secreting estrogen * Granulosa: enzyme aromatase (makes beta estradiol) * Theca: androgen precurosor
41
Hormonal Regulation: Selection of Dominant Follicle and Late Follicular Phase
* Follicle enlarges and increases estrogen secretion * Causes negative feedback inhibition * Gn levels decline (esp. FSH) * Granulosa secrete inhibin to prevent FSH * Selection because negative feedback limits FSH * Granulosa cells develop LH receptors in late follicular phase and start reponding to LH
42
Hormonal Regulation: LH surge and Ovulation
* Estrogen from follicle cross threshold and estrogen causes postive feedback * Causes rapid rise in LH ("surge") * Causes ovulation * Just prior to ovulation, LH causes a blip of progesterone secretion (needed for ovulation) * First division of meisosis occurs just prior to ovulation
43
Hormonal Regulation: Luteal Phase
* LH stimulates formation of corpus luteum * Secretes estrogen and progesterone * Negative feedback on Gn * Prevents further follicle development and ovulation * LH levels fall below a threshold and corpus luteum regresses * Release hypothalamus and pituitary from negative feedback inhibition * FSH and LH steadliy increase to start new cycle
44
Complete Diagram of Female Cycle
45
Coordination of Uterine Events
* Endometrium into functional layer under estrogen and progesterone control * Basal layer that regenerates functional layer after menustration * Middle and Late Follicular Phase: * High estrogen cause proliferation (**proliferative phase**); cervix secrete thin watery mucus * Inductiov of progesterone receptors * Luteal Phase * Progestrone prevent further proliferation * Blood vessel growth * **Secretory Phase** * Cervix secrete thick mucus * Inhibit contractions * Menustration * Drop in progestrone and estrogen * Vasocontriction causes ischemia * Later vasodialation to causes bleeding and contraction of myometrium
46
Menorrhagiae Dysmenorrhea
* Menorrhagiae: excessive uterine bleeding * Dysmenorrhea: painful menustration
47
Leiomyoma
* "Fibroids" * Benign growths in myometrium * Abnormal entometrial growth over fibroids leads to excessive bleeding * More common in older women, have hystorectomy
48
Unopposed Estrogen
* Occurs in PCOS * PCOS: annovulation: no switch to luetal or secretory phase * Lots of estrogen and not a lot of progesterone * Endometrium keeps proliferating * Miss a bunch of periods and then have a really bad period * Increased risk for endometrial cancer * Treated with hormonal contraceptives
49
Hyperprolactinemia: Prolactin regulation
* Stimulates milk production in the breast/growth * Estrogen and progesterone prevent lactation * Suckling stimulates mechanoreceptors * Magnocellular Cell: * Release oxytocin from posterior pituitary * Milk ejections from myoepithelial cells * Parvocellular cell that release dopamine at the median eminence * Dopamine travel to the anterior pituitary via hypophyseal portal vessels and inhibit prolactin secretion * Suckling inhibits dopamine release​
50
Hyperprolactinemia: Causes and Treatments
* Pituitary tumor (prolactinoma) that secretes prolactin * Cause infertility because prolactin inhibits GnRH secretion * Low GnRH, low FSH and LH * Hypogonadotropic hypogonadism * anovulation * amenorrhea and galactorrhea * osteoprosis * Dopamine antagonists can cause hyperprolactima * Gonadal hormone treatment * First line treatment is dopamine agonist * bromocriptine and cabergoline
51
PCOS: Description
* Most common cause of anovulatory infertility * Chronic ovulation problems with hyperandrogenism * Amenorrhea or oligomenorrhea * Hirsutism, acne, hair loss on scalp * Ovaries enlarged with multiple immature follicels * Hyperplasia of theca cells * Fewer granulosa cells * No domininant follicle chosen and on LH surge * Often insulin resistant: hyperinsulinemia , greater T2DM risk * Ultrasound show "necklace of black pearls"
52
Endocrine disturbances in PCOS
* Normal follicle development when estrogen and progesterone levels drop due to degeneration of corpus luteum * Granulosa respond to FSH and Theca to LH * In PCOS, LH secretion is elevated (FSH the same or decreased) * Theca cells and androgens produced but there is not enough FSH to stimulate granulosa cells * Failure of follicle development to progress * Androgen converted to estrogens in adipose tissue * Abnormal feedback regulation * LH continues to be high compared to FSH * Hyperinsulinemia contributes because insulin stimulates androgen production
53
Treatment for PCOS: Hormonal Contraceptives
* Decrease hyperandrogenism and negative effects on uterus * Estrogen and progestrone restore normal LH levels * PCOS causes there to be unopposed estrogen because never progress to luteal phase that has progesterone * Continued proliferation leading to menorrhagia * Increases risk for endometrial cancer
54
Treatment for PCOS: Clomiphene
* SERM * In hypothalmus and anterior pituirtary, acts as estrogen antagonist * prevents negative feedback effect of estrogen, allows FSH secretion to increase so that follicle development can be stimulated * Taken at a certain time in cycle to snap out of bad habits * Potential for mulitple ovulations * Alters uterine environment making it harder to concieve * Usually 1st line in those wanting to concieve
55
Treatment for PCOS: Aromatase inhibitors
* Letrozole and anastrozole efficicay in ovulation induction * Prevent androgens from converting to estrogens * Limit estrogen negative feedback on GnRH * Shorter half-life allowing normal estrogen secretion later in cycle * Less risk for multiple ovulations * More estrogen stimulation of endometrial development during proliferative phase
56
Tratement for PCOS: insulin sensatizers
* Metformin * Safe and effective in lowering androgen levels
57
Treatment for PCOS: Gonadotropins
* Exogenous FSH * Menotropin * mixture of gonadotropins from menopausal urine * Urofollitropin * purified FSH from urine * Follitropin * Recombinant FSH * FSH may lead to multiple ovulations * Ovarian hyperstimulation syndrome, increased vascular permeability (edema, nausea, abdominal pain) * Severe: clotting abnormalities, renal failure, respiratory distress
58
Treatment for PCOS: Ovarian Surgery
* Induce damage to ovarian tissue * Breaks the cycle of androgen production and abnormal negative feedback * No risks of hyperstimulation or multiple pregnancy
59
PCOS Treatments for women who do not want to concieve
* Hormonal Contraceptives * Weight Loss * Metformin
60
PCOS treatments for women who **do** want to concieve
* Clomiphene * Weight Loss * Aromatase Inhibitors * Metformin * FSH * Surgery
61
Definition of Conception
* Implantation of fertilized embryo * Measure by increase in chorionic gonadotropin * Measure ovulation by LH surge
62
Hormonal Contraceptive: MOA
* Suppress the secretion of gonadotropins (FSH and LH) thorugh negative feedback inhibition * Inhibit during luteal phase * Suppress ovulation * Prevent rise in FSH needed for initiation of follicle development and selection of dominant follicle * Prevents LH surge needed to trigger ovulation * In follicular phase, estrogen makes thin water mucus that sperm can traverse * In luteal phase, progesterone makes thick mucus. Progesterone in HC does this * Reduce endometrial growth and interfere with implantation * Side effect: mid-cycle bleeding from abnormal endometrial proliferation
63
Combination Contraceptives
* Estrogen and progestin * Placebo causes withdrawl bleed * Sign not prego, but not essential * Continuous for women who suffer menorrhagiae or dysmenorrhea
64
Progesterone Only Contraceptives
* Low Dose Pills * Not as reliable at preventing ovulation but work by thickening cervical mucus * Must be taken at the same time everyday * Good for lactating mothers * Long-Acting Methods * Depo-Provera * Injected every 3 months * Inhibition of estrogen may cause loss in bone density
65
Emergency Contraception
* Block or delay ovulation since sperm can be in reproductive tract for days * Plan B (levonorgesterol in higher dose) * Negative feedback inhibitior of GnRH * Only works if taken **before** LH surge * Use within 12 hrs, but can be effective for 5 days * Ella (ulipristal acetate) * selective progesterone receptor modulator * Blocks progesterone action in follicle * Small increase in progesterone caused by LH surge * Delay ovulation even if begining of LH surge has already occured * Not effective if taken after the peak of LH surge * May affect endometrium, but very low doses so maybe not
66
Hormonal Contraceptives: Risks
* Cardiovascular Risk * Rare in young women and pregnancy increases these risks even greater * Promote thrombosis (VTE); pulmonary embolism, MI or stroke * Clotting due to estrogen * Newer progestin (drospirenone, desogestrel) have higher risk than older (levonorgestrel) * Breast Cancer * Tumors stimulated by estrogen * Estrogen and Progesteronen promote breast growth * No increase in breast cancer (but study done in older women) *
67
Hormonal Contraceptives: Benefits
* Menstural Symptoms: * Menorrhagia, dysmenorrhea, PCOS * Endometrial Cancer: * Decreased endometrial proliferation * Lowest risk in those of HC for longest * Ovarian Cancer: * Lowest risk in those on HC for longest * Androgen Secretion * Treat hyperandrogenism because decrease gonadotropin androgen secretion * Reduce severity of acne
68
Mifepristone
* Progesterone antagonist * Terminate pregnancy in first 7 weeks * Need progesterone to keep gestation * Progesterone maintains endometrium and quiet myometrium * Mifepristone and then prostaglandins * prostaglandins induce myometrial contractions * Mifepristone induces shedding of endometrium * Ella progesterone antagonist is used at a much lower dose
69
Acrosome Reaction
* Sperm matures as goes through female reproductive tract * Acrosome: large vesicle in head of sperm; contains digestive enzymes * Sperm bind to zona pellucida; acrosome reaction is undergone * Release of digest enzyme; allows sperm to burrow through zona pellucida * Many sperm undergo acrosome reaction, but only one “wins” * Once sperm membrane fuses with egg membrane; triggers a reaction in the ovum (cortical reaction)
70
Cortical Reaction
* Exocytosis of vesicles * Change the zona pellucida; zona hardening * Other sperms that are bound fall off and prevents other sperms from fertilizing the egg * Zona pellucida stay with the fertilized egg (conceptus) * Give rise to embryo and extra embryonic tissue * Sperm-egg fusion stimulated the second division of meiosis * Male and Female pronucleus fuse and then divide to make zygote (other female nucleus is the polar body)
71
First Cell Divisions in Pregnancy
* First cell divisions through fallopian tube occur without any growth; cleavage * 70-100 cells * Zona pellucida prevents it from implanting where it shouldn’t * Blastocyst
72
Implantation-stage conceptus: blastocyst
* Once reaches the uterus, there is zona hatching * Two kinds of cell in blastocyst * Trophoblast: Outer layer that forms extra embryonic tissue (chorion) * Inner Cell Mass: Cell concentrated on one side; forms embryo
73
Trophoblast
* Trophoblast is sticky and adheres to endometrium * Promotes proliferation * Divides into two groups * Syncytial trophoblast: cell membrane break down, so many nuclei in one membrane * Invasive into endometrium * Proteolytic enzymes * Makes chorionic gonadotropin * Makes lacuna * Cellular trophoblast: normal cells * Forms chorionic villi
74
Implantation
* Occurs 6 to 7 days after fertilization * syncytial trophoblast * invasisive and proteolytic enzymes * embyro nourished by digestion of endometrium * Digestion of endometrial tissue creates lacunae * produce chorionic gonadotropin * Pregnancy test * LH analog, maintains corpus luteum * Cellular trophobasts create branched structures, known as chorionic villi * developing embryo forms a disc that pulls away from the proliferating trophoblast to create a new space * amniotic cavity
75
The Placenta
* from the trophoblast and the endometrium * during pregnancy the endometrium is known as the **decidua** * Placenta 5 wks after implantation * fetal part of the placenta, or chorion, is made up of the chorionic villi * branched * blood vessels just under trophoblast layer * villi protrude into large spaces (lacunae) in the decidua * maternal blood into lacunae to wash over villi * exchange of nutrients, wastes, and blood gases * Source of estrogen and progesterone after 8 weeks of pregnancy
76
Development of the Amnion
* Development of the amnion * Fluid filled * Chorion develops on one side and then fuses with the amnion * Chorion will be on one side of the uterus
77
Estrogen and Progesterone in Pregnancy: Immplantation
* Gonadosteroid make the uterus prime for immplantation * Estrogen in follicular phase proliferates endometrium * Progesterone in luteal phase stimulates secretion and promotes blood vessel growth * Estrogen and Progesterone by corpus luteum * Early in pregnangy CL stimualted by HCG * By 4 weeks there are detectable levels of HCG
78
Estrogen and Progesterone in Pregnancy: Gestation
* Progesterone: smooth muscle relaxation in the myometrium, developmental changes in endometrium for decidua formation * Progesterone supplementation in women who have a history of preterm labor
79
Graph of Hormonal Changes in Pregnancy
80
Estrogen and Progesterone in Pregnancy: Preparation for Lactation
* Progesterone stimulates growth of milk-producing cells in the glands * Estrogen stimulates growth of duct cells * Estrogen stimulated prolactin
81
Partruition
* Delivery of infant and placenta * Estrogen stimulates proliferation in the myometrium * synthesis of gap junctions between myometrial smooth muscle cells * Coordinated contraction * synthesis of enzymes involved in prostaglandin synthesis * Prostaglandin cervical ripening * Soft, flexible and dialated * Prostaglandins stimualte myometrial contractions * oxytocin is the strongest stimulator of uterine contractions * estrogen increases responsiveness to oxytocin by increasing expression of oxytocin receptors
82
Partruition: Hormonal Loop
* Head pushes head against the cervix * Stretch receptors in the cervix * Feed onto the hypothalamus * Activate neurosecretory cells to release more oxytocin * Positive feeback stimulation to make sure that the baby is born “all the way”
83
Strucutre of the Breast
* Milk is produced by secretory structures known as alveoli * Alveoli are arranged in clusters called lobules * The lobules are connected to outlets at the nipple by ducts * The alveoli are surrounded by special contractile cells known as myoepithelial cells.
84
congenital adrenal hyperplasia
* Problems with sexual differentiation of XX infants * when excess androgens are produced during development * can be due to an adrenal tumor in the mother * most often in the disorder known as congenital adrenal hyperplasia * defects in the enzymatic pathways that produce cortisol * Low cortisol cannot exert negative feedback regulation on the secretion of the pituitary hormone ACTH, which stimulates hormone production by the adrenal gland * adrenal glands produce large amounts of androgens, which have the effect of masculinizing XX females * precocious sexual development in males
85
Cryptorchidism
* Failure of both testes to descend into the scrotum by birth * Surgical correction of cryptorchidism is done ideally before 2 years of age and is known as orchiopexy * Cryptorchidism increases risk for testicular cancer and orchiopexy reduces this risk
86
Testicular cancer
* most common malignancy in young men * vast majority of testicular cancers (95%) are germ cell tumors * these tumors arise when there is disrupted growth and development of germ cell precursors * the cure rate approaches 80% * removal of the tumor, followed by radiation, or chemotherapy * chemotherapy drug **cisplatin** has proved to be very effective in the treatment of testicular cancer
87
Benign Prostatic Hyperplasia
* non-cancerous growth of the prostate gland * pelvic pain and difficulty in urination * prostate is more responsive to DHT, one therapeutic approach uses 5-a-reductase inhibitors, such as dutasteride and finasteride * Another medical approach is to use a–blockers (an example is tamsulosin), which relax smooth muscle in the prostate and urethra to ease urinary symptoms * Surgical resection of the enlarged prostate can also be done using an instrument inserted in the urethra.
88
Prostate Cancer
* most frequently diagnosed cancer among men in the United States * Detection of prostate tumors was traditionally done by digital rectal examination * Prostate-specific antigen (PSA) is a protein produced by the prostate, and its levels rise in the blood when the prostate enlarges, as it would if a tumor was present * high rates of false positives and false negatives * Treat with hormonal therapy * Radiation * prostatectomy
89
Breast Cancer
* mammography also causes overdiagnosis, that is, the identification of tumors that may not be otherwise clinically significant in a woman’s lifetime * non-invasive (confined to breast ducts or lobules) or invasive (spread to surrounding connective tissue) * Another term for non-invasive breast cancer is carcinoma in situ * To determine whether breast cancer has metastasized, the axillary lymph nodes (lymph nodes of the armpit) are dissected and examined. * over-expresses hormone receptors (either for estrogen or progesterone) or the growth factor receptor HER2 * treat it with drugs that interfere with estrogen, such as tamoxifen (which is a selective estrogen receptor modulator; SERM) or letrozole (an aromatase inhibitor that prevents estrogen synthesis). Tumors that are positive for HER2 are treated with trastuzumab (tradename: Herceptin), an antibody-based drug that binds to the receptor and prevents cell growth.
90
Breast Cancer Surgery
* mastectomy (removal of the breast) or lumpectomy, in which the tumor and surrounding tissue are removed * lumpectomy after radiation * Adjuvant therapy refers to any of the various systemic therapies: chemotherapy, hormone therapy, or trastuzumab.
91
Breast Cancer and HRT
* hormone replacement therapy increased the risk of heart disease and breast cancer
92
PID
* acute infection of the upper reproductive tract in women, namely endometritis * salpingitis (infection of the fallopian tubes) * oophoritis (infection of the ovaries) * Usually by the clap * pelvic pain, tenderness upon palpation, and (sometimes, but not always) vaginal discharge * Can lead to infertility and tubal dysfunction * Treat with antibiotics
93
Endometriosis
* endometrial tissue is found in ectopic locations, usually in the pelvic cavity * pelvic pain, tissue damage, and lowered fertility * retrograde menstruation (i.e. menstruation through the fallopian tube instead of the cervix) allows ectopic endometrial tissue to implant in the pelvic cavity * persist there due to an insufficient immune response * treated surgically, or with drugs that decrease estrogen levels such as oral contraceptives or the GnRH agonist leuprolide
94
Dysmenorrhea
* painful menstruation * High prostaglandin levels * sensitize pain fibers in the uterus * treated effectively with NSAIDs (non-steroidal anti-inflammatory drugs) * oral contraceptives * Progesterone opposes prostaglandin function * less endometrium overal lowers prostaglandin secretion as well
95
Menopause
* end of ovarian follicle production, there is also a marked drop in production of estrogen * decrease in the size of the breasts and uterus * bone density and cardiovascular system * lack of estrogen leading to hot flash * HRT for vaginal dryness and hot flash and osteoporosis * Treatment of estrogen loss: * selective estrogen receptor modulators (SERMs), such as raloxifen * act as estrogen antagonists in some tissues, while acting as estrogen agonists in other tissues * Raloxifene may now also be prescribed to prevent breast cancer in post-menopausal women at high risk for invasive breast cancer.